Status:
RECRUITING
Prospective Cohort of Patients With Hepatocellular Carcinoma in France
Lead Sponsor:
Centre Hospitalier Universitaire, Amiens
Collaborating Sponsors:
Biobanque de Picardie
Société Nationale Française de Gastroentérologie
Conditions:
Cancer of Liver
Hepatocellular Carcinoma
Eligibility:
All Genders
18+ years
Brief Summary
Hepatocellular carcinoma (HCC) occurs in 90% of cirrhosis primary liver cancers. In France, 8,500 new cases of HCC occur each year, and about 8,000 deaths per year are related to this cancer. The 5-ye...
Eligibility Criteria
Inclusion
- New cases of HCC
- suspected case of HCC regardless of the cause, stage, treatment
- Known HCC: drug treatment for recurrence or progression
Exclusion
- Associated serious condition threatening life in the short term (with the exception of liver disease itself)
- So-called vulnerable populations: minors, persons under guardianship or temporary guardianship, or person deprived of their liberty by an administrative or judicial decision
Key Trial Info
Start Date :
September 26 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT04348838
Start Date
September 26 2019
End Date
December 31 2027
Last Update
June 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Amiens
Amiens, France, 80480